SjAPI, the First Functionally Characterized Ascaris-Type Protease Inhibitor from Animal Venoms

PLoS ONE

Volumn 8, Issue 3, 2013, Pages

  Chen, Zongyun ^a   Wang, Bin ^a   Hu, Jun ^a   Yang, Weishan ^a   Cao, Zhijian ^a   Zhuo, Renxi ^a   Li, Wenxin ^a   Wu, Yingliang ^a  

^a WUHAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALANYLALANYLVALINE; BUTHUS MARTENSII ASCARIS TYPE PROTEASE INHIBITOR; CHAERILUS TRICOSTATUS ASCARIS TYPE PROTEASE INHIBITOR; CHYMOTRYPSIN A; COMPLEMENTARY DNA; CYSTEINE; ELASTASE; POLYPEPTIDE; PROTEINASE INHIBITOR; RECOMBINANT PROTEIN; RECOMBINANT SCORPIOPS JENDEKI ASCARIS TYPE PROTEASE INHIBITOR; SCORPION VENOM; SCORPIOPS JENDEKI ASCARIS TYPE PROTEASE INHIBITOR 2; SCORPIOPS JENDEKI ASCARIS TYPE PROTEASE INHIBITOR M1; SCORPIOPS JENDEKI ASCARIS TYPE PROTEASE INHIBITOR M2; SCORPIOPS JENDEKI ASCARIS TYPE PROTEASE INHIBITOR M3; SCORPIOPS JENDEKI ASCARIS TYPE PROTEASE INHIBITOR M4; SCORPIOPS JENDEKI ASCARIS TYPE PROTEASE INHIBITOR M5; SCORPIOPS JENDEKI ASCARIS TYPE PROTEASE INHIBITOR M6; SERINE PROTEINASE INHIBITOR; UNCLASSIFIED DRUG;

ARTICLE; BIOINFORMATICS; CONTROLLED STUDY; DISULFIDE BOND; DNA LIBRARY; DRUG DETERMINATION; DRUG PURIFICATION; DRUG STRUCTURE; ENZYME INHIBITION; MOLECULAR CLONING; NONHUMAN; PEPTIDE ANALYSIS; PROTEIN EXPRESSION; PROTEIN FOLDING; SCORPION; SCORPIOPS JENDEKI; SCREENING TEST; SEQUENCE ANALYSIS;

AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; CHYMOTRYPSIN; GENE LIBRARY; MOLECULAR DYNAMICS SIMULATION; PANCREATIC ELASTASE; PHYLOGENY; SCORPION VENOMS; SEQUENCE ALIGNMENT; SERINE PROTEINASE INHIBITORS;

EID: 84875341349     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0057529     Document Type: Article

References (41)

1. Van Gent D, Sharp P, Morgan K, Kalsheker N, (2003) Serpins: structure, function and molecular evolution. Int J Biochem Cell Biol 35: 1536-1547.
2. Zhao Y, Sun W, Zhang P, Chi H, Zhang MJ, et al. (2012) Nematode sperm maturation triggered by protease involves sperm-secreted serine protease inhibitor (Serpin). Proc Natl Acad Sci U S A 109: 1542-1547.
3. Jin X, Deng L, Li H, Zhang Z, He Q, et al. (2011) Identification and characterization of a serine protease inhibitor with two trypsin inhibitor-like domains from the human hookworm Ancylostoma duodenale. Parasitol Res 108: 287-295.
4. Moreau T, Baranger K, Dade S, Dallet-Choisy S, Guyot N, et al. (2008) Multifaceted roles of human elafin and secretory leukocyte proteinase inhibitor (SLPI), two serine protease inhibitors of the chelonianin family. Biochimie 90: 284-295.
5. Davis AE 3rd, Lu F, Mejia P (2010) C1 inhibitor, a multi-functional serine protease inhibitor. Thromb Haemost 104: 886-893.
6. Fook JM, Macedo LL, Moura GE, Teixeira FM, Oliveira AS, et al. (2005) A serine proteinase inhibitor isolated from Tamarindus indica seeds and its effects on the release of human neutrophil elastase. Life Sci 76: 2881-2891.
7. Gomes CE, Barbosa AE, Macedo LL, Pitanga JC, Moura FT, et al. (2005) Effect of trypsin inhibitor from Crotalaria pallida seeds on Callosobruchus maculatus (cowpea weevil) and Ceratitis capitata (fruit fly). Plant Physiol Biochem 43: 1095-1102.
8. Minagawa S, Ishida M, Shimakura K, Nagashima Y, Shiomi K, (1997) Isolation and amino acid sequences of two Kunitz-type protease inhibitors from the sea anemone Anthopleura aff. xanthogrammica. Comp Biochem Physiol B Biochem Mol Biol 118: 381-386.
9. Cheng YC, Yan FJ, Chang LS, (2005) Taiwan cobra chymotrypsin inhibitor: cloning, functional expression and gene organization. Biochim Biophys Acta 1747: 213-220.
10. Lu J, Yang H, Yu H, Gao W, Lai R, et al. (2008) A novel serine protease inhibitor from Bungarus fasciatus venom. Peptides 29: 369-374.
11. Fry BG, Roelants K, Champagne DE, Scheib H, Tyndall JD, et al. (2009) The toxicogenomic multiverse: convergent recruitment of proteins into animal venoms. Annu Rev Genomics Hum Genet 10: 483-511.
12. Babin DR, Peanasky RJ, Goos SM, (1984) The isoinhibitors of chymotrypsin/elastase from Ascaris lumbricoides: the primary structure. Arch Biochem Biophys 232: 143-161.
13. Peanasky RJ, Bentz Y, Homandberg GA, Minor ST, Babin DR, (1984) The isoinhibitors of chymotrypsin/elastase from Ascaris lumbricoides: the reactive site. Arch Biochem Biophys 232: 135-142.
14. Peanasky RJ, Bentz Y, Paulson B, Graham DL, Babin DR, (1984) The isoinhibitors of chymotrypsin/elastase from Ascaris lumbricoides: isolation by affinity chromatography and association with the enzymes. Arch Biochem Biophys 232: 127-134.
15. Gronenborn AM, Nilges M, Peanasky RJ, Clore GM, (1990) Sequential resonance assignment and secondary structure determination of the Ascaris trypsin inhibitor, a member of a novel class of proteinase inhibitors. Biochemistry 29: 183-189.
16. Huang K, Strynadka NC, Bernard VD, Peanasky RJ, James MN, (1994) The molecular structure of the complex of Ascaris chymotrypsin/elastase inhibitor with porcine elastase. Structure 2: 679-689.
17. Mignogna G, Pascarella S, Wechselberger C, Hinterleitner C, Mollay C, et al. (1996) BSTI, a trypsin inhibitor from skin secretions of Bombina bombina related to protease inhibitors of nematodes. Protein Sci 5: 357-362.
18. Cierpicki T, Bania J, Otlewski J, (2000) NMR solution structure of Apis mellifera chymotrypsin/cathepsin G inhibitor-1 (AMCI-1): structural similarity with Ascaris protease inhibitors. Protein Sci 9: 976-984.
19. Chen ZY, Hu YT, Yang WS, He YW, Feng J, et al. (2012) Hg1, novel peptide inhibitor specific for Kv1.3 channels from first scorpion Kunitz-type potassium channel toxin family. J Biol Chem 287: 13813-13821.
20. Ma Y, He Y, Zhao R, Wu Y, Li W, et al. (2011) Extreme diversity of scorpion venom peptides and proteins revealed by transcriptomic analysis: Implication for proteome evolution of scorpion venom arsenal. J Proteomics 75(5): 1563-1576.
21. Zeng XC, Li WX, Zhu SY, Peng F, Jiang DH, et al. (2000) Cloning and characterization of the cDNA sequences of two venom peptides from Chinese scorpion Buthus martensii Karsch (BmK). Toxicon 38: 893-899.
22. Bendtsen JD, Nielsen H, von Heijne G, Brunak S, (2004) Improved prediction of signal peptides: SignalP 3.0. J Mol Biol 340: 783-795.
23. Han S, Yi H, Yin SJ, Chen ZY, Liu H, et al. (2008) Structural basis of a potent peptide inhibitor designed for Kv1.3 channel, a therapeutic target of autoimmune disease. J Biol Chem 283: 19058-19065.
24. Wu Y, Cao Z, Yi H, Jiang D, Mao X, et al. (2004) Simulation of the interaction between ScyTx and small conductance calcium-activated potassium channel by docking and MM-PBSA. Biophys J 87: 105-112.
25. Zhao R, Dai H, Qiu S, Li T, He Y, et al. (2011) SdPI, the first functionally characterized Kunitz-type trypsin inhibitor from scorpion venom. PLoS One 6: e27548.
26. Kim H, Chu TT, Kim DY, Kim DR, Nguyen CM, et al. (2008) The crystal structure of guamerin in complex with chymotrypsin and the development of an elastase-specific inhibitor. J Mol Biol 376: 184-192.
27. Grasberger BL, Clore GM, Gronenborn AM, (1994) High-resolution structure of Ascaris trypsin inhibitor in solution: direct evidence for a pH-induced conformational transition in the reactive site. Structure 2: 669-678.
28. Rios-Steiner JL, Murakami MT, Tulinsky A, Arni RK, (2007) Active and exo-site inhibition of human factor Xa: structure of des-Gla factor Xa inhibited by NAP5, a potent nematode anticoagulant protein from Ancylostoma caninum. J Mol Biol 371: 774-786.
29. Lee HJ, Im H, (2003) Purification of recombinant plasminogen activator inhibitor-1 in the active conformation by refolding from inclusion bodies. Protein Expr Purif 31: 99-107.
30. Otlewski J, Jaskolski M, Buczek O, Cierpicki T, Czapinska H, et al. (2001) Structure-function relationship of serine protease-protein inhibitor interaction. Acta Biochim Pol 48: 419-428.
31. Hoogstraten CG, Choe S, Westler WM, Markley JL, (1995) Comparison of the accuracy of protein solution structures derived from conventional and network-edited NOESY data. Protein Sci 4: 2289-2299.
32. Liu J, Prakash O, Cai M, Gong Y, Huang Y, et al. (1996) Solution structure and backbone dynamics of recombinant Cucurbita maxima trypsin inhibitor-V determined by NMR spectroscopy. Biochemistry 35: 1516-1524.
33. McPhalen CA, James MN, (1987) Crystal and molecular structure of the serine proteinase inhibitor CI-2 from barley seeds. Biochemistry 26: 261-269.
34. Salameh MA, Soares AS, Hockla A, Radisky DC, Radisky ES, (2011) The P(2)' residue is a key determinant of mesotrypsin specificity: engineering a high-affinity inhibitor with anticancer activity. Biochem J 440: 95-105.
35. Berg DT, Gerlitz B, Shang J, Smith T, Santa P, et al. (2003) Engineering the proteolytic specificity of activated protein C improves its pharmacological properties. Proc Natl Acad Sci U S A 100: 4423-4428.
36. Froy O, Sagiv T, Poreh M, Urbach D, Zilberberg N, et al. (1999) Dynamic diversification from a putative common ancestor of scorpion toxins affecting sodium, potassium, and chloride channels. J Mol Evol 48: 187-196.
37. He QY, He QZ, Deng XC, Yao L, Meng E, et al. (2008) ATDB: a uni-database platform for animal toxins. Nucleic Acids Res 36: D293-297.
38. He YY, Liu SB, Lee WH, Qian JQ, Zhang Y, (2008) Isolation, expression and characterization of a novel dual serine protease inhibitor, OH-TCI, from king cobra venom. Peptides 29: 1692-1699.
39. Peigneur S, Billen B, Derua R, Waelkens E, Debaveye S, et al. (2011) A bifunctional sea anemone peptide with Kunitz type protease and potassium channel inhibiting properties. Biochem Pharmacol 82: 81-90.
40. Yuan CH, He QY, Peng K, Diao JB, Jiang LP, et al. (2008) Discovery of a distinct superfamily of Kunitz-type toxin (KTT) from tarantulas. PLoS One 3: e3414.
41. Lee J, Natarajan M, Nashine VC, Socolich M, Vo T, et al. (2008) Surface sites for engineering allosteric control in proteins. Science 322: 438-442.